Danish Pharma Stock News

Share buy-back puts Rockwool (CPSE:ROCK B) in focus Rockwool (CPSE:ROCK B) has moved into the spotlight after launching a share buy-back programme of up to €150m. Recent disclosures show 4,786,356 B shares held, equal to 2.26% of share capital. See our latest analysis for Rockwool. The new buy-back comes against a softer share price backdrop, with a 30-day share price return showing a 5.26% decline and a 1-year total shareholder return showing a 14.64% decline. The 3-year total shareholder...

Vattenfall has ordered Vestas turbines featuring low-emissions steel for the 63 MW Clashindarroch II wind farm in Scotland, marking the first time this lower-impact material has been used in a commercial wind project. This step highlights how Vestas is integrating cleaner materials into turbine manufacturing, potentially reshaping sustainability standards across the wind supply chain. We’ll now explore how this pioneering use of low-emissions steel could influence Vestas’ investment...

ISS has announced that it previously secured a three-year Integrated Facility Services contract, worth close to DKK 300 million annually, to become the primary facilities partner for a major life sciences and pharmaceutical company across four Swiss locations starting in the second quarter of 2026. By moving from a subcontractor role to direct ownership of a wide range of technical, cleaning, logistics and laboratory services under one integrated FM setup, ISS is deepening its position in a...

RTX (CPSE:RTX) Q1 2026 earnings snapshot RTX (CPSE:RTX) opened its 2026 financial year with Q1 revenue of DKK115.9 million, a basic EPS loss of DKK1, and net income excluding extra items at a loss of DKK8.3 million. This sets a cautious tone around profitability to start the year. Over the prior year, quarterly revenue has moved between DKK104.0 million in Q1 2025 and DKK165.5 million in Q2 2025. Basic EPS ranged from a loss of DKK0.90 in Q1 2025 to a high of DKK0.99 in Q2 2025, highlighting...

Alm. Brand (CPSE:ALMB) has wrapped up FY 2025 with fourth quarter revenue of DKK3.97b and basic EPS of DKK0.20, closing out a year where trailing twelve month revenue came in at DKK14.0b and EPS at DKK0.80. Over recent quarters the company has seen revenue range from DKK3.26b in Q1 2025 to DKK3.97b in Q4, while quarterly EPS moved from DKK0.11 to DKK0.20 across the same period. This has set the backdrop for earnings that lifted net margins to 8.4% from 5.7% a year earlier, a combination of...

It's not a stretch to say that Carlsberg A/S' ( CPH:CARL B ) price-to-earnings (or "P/E") ratio of 16.8x right now...

In January 2026, Tryg A/S reported fourth-quarter 2025 earnings, with net income rising to DKK 1,277 million from DKK 786 million a year earlier, and the company also moved past the ex-dividend date for a DKK 2.05 cash payout on January 23, 2026. Alongside the stronger quarterly profit, recent share grants to senior management highlight how incentives at Tryg are increasingly tied to the company’s performance. Next, we’ll examine how Tryg’s sharp fourth-quarter profit increase shapes its...

Most readers would already be aware that UIE's (CPH:UIE) stock increased significantly by 18% over the past three...

In January 2026, Ørsted welcomed the newly signed Joint Offshore Wind Investment Pact and the North Sea Wind Pact, which aim to coordinate offshore wind deployment across Europe’s North Seas and support large-scale clean energy development. By targeting up to 15 gigawatts of new offshore capacity per year and seeking more predictable investment frameworks, these agreements could materially reshape how offshore wind projects are planned, financed, and operated across the region. We’ll now...

DSV (CPSE:DSV) has started building a new southwest regional headquarters in Mesa, Arizona. The $14.5 million logistics hub is designed to support air, sea, and road transport for semiconductor and technology clients. See our latest analysis for DSV. The Mesa project lands at a time when DSV’s share price has a 90 day return of 26% and a 30 day return of 7.5%, while its 1 year total shareholder return sits at 19.36%, suggesting momentum has been building over both shorter and longer...

Key Insights Royal Unibrew's significant individual investors ownership suggests that the key decisions are influenced...

Amid renewed trade and geopolitical uncertainty, the pan-European STOXX Europe 600 Index recently ended 0.98% lower, reflecting a broader decline across major European stock indexes. Despite this downturn, opportunities may exist for investors seeking stocks that could be trading below their estimated value, particularly in sectors where business activity remains positive and confidence is on the rise. Identifying undervalued stocks often involves looking at companies with strong fundamentals...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

GreenMobility A/S ( CPH:GREENM ) shares have retraced a considerable 27% in the last month, reversing a fair amount of...

A.P. Møller - Mærsk (CPSE:MAERSK B) is back in focus after renewed security risks in the Red Sea, as Houthi attacks prompt shipping firms to reroute vessels, extend transit times and reassess operational risk. See our latest analysis for A.P. Møller - Mærsk. The renewed Red Sea risk is arriving at a time when A.P. Møller - Mærsk’s shares have already shown stronger momentum, with a 90 day share price return of 8.92% and a 1 year total shareholder return of 61.55%. This points to building...

In January 2026, Genmab reported that worldwide 2025 net trade sales of DARZALEX, as reported by Johnson & Johnson, reached US$14.35 billion, generating ongoing royalty revenue for Genmab, and released positive topline Phase 3 EPCORE DLBCL-1 results showing epcoritamab monotherapy improved progression-free survival in relapsed or refractory DLBCL versus standard regimens. The combination of a very large, royalty-generating DARZALEX franchise and clinically meaningful Phase 3 data for...

Vestas Wind Systems (CPSE:VWS) is back in focus after European countries agreed on plans for 100 GW of shared offshore wind capacity in the North Sea, and Vestas shares rose 5.2% on the news. See our latest analysis for Vestas Wind Systems. The North Sea pact has arrived on top of a strong run in Vestas’ shares, with a 90 day share price return of 46.61% and a 1 year total shareholder return of 103.98% from a starting point that had seen weaker multi year outcomes. Recent gains, including a...

A.P. Møller - Mærsk has resumed part of its Red Sea–Suez Canal sailings with conditional routing, while also appointing Charles van der Steene as Regional Managing Director for the Indian Subcontinent, Middle East & Africa from 1 January 2026 and progressing a share buy-back program of up to DKK 14.40 billion announced in February 2025. Together, these developments highlight Maersk’s mix of operational risk management, regional leadership continuity and capital return decisions at a time of...

Amid renewed trade and geopolitical uncertainty, the European stock market has seen declines, with the pan-European STOXX Europe 600 Index ending 0.98% lower. Despite these challenges, business activity in the eurozone remains positive, offering a glimmer of optimism for investors seeking opportunities in undervalued stocks. In this context, identifying stocks trading below their intrinsic value can be crucial for investors looking to capitalize on potential market inefficiencies and position...

Share buy-back launch puts Aktieselskabet Schouw (CPSE:SCHO) in focus Aktieselskabet Schouw (CPSE:SCHO) has moved into the spotlight after launching a share buy-back programme of up to DKK 240 million through 2026, a capital allocation decision that can influence both valuation and trading interest. See our latest analysis for Aktieselskabet Schouw. That buy-back announcement lands after a steady run in the share price, with a 30-day share price return of 4.67% and a 90-day share price return...

Event driven focus on Demant’s evolving platform Demant (CPSE:DEMANT) is refocusing around a comprehensive audio healthcare platform. The platform is built on custom chipsets, on device AI, and an integrated retail and diagnostics footprint that ties hardware, software, and clinical services together. See our latest analysis for Demant. At a DKK233.2 share price, Demant’s recent 1 month share price return of 8.97% and year to date share price return of 9.28% sit against a 1 year total...

The Board of Directors of Alm. Brand (CPSE:ALMB) has recommended an ordinary dividend of DKK 0.66 per share for the 2025 financial year, corresponding to a total payout of DKK 0.9b. See our latest analysis for Alm. Brand. At a share price of DKK18.16, Alm. Brand has had a mildly weaker recent patch, with a 1 month share price return of a 3.51% decline, even though its 1 year total shareholder return of 25.93% points to momentum that has built over a longer horizon. If this dividend news has...

With its stock down 12% over the past month, it is easy to disregard Zealand Pharma (CPH:ZEAL). However, a closer look...

Coloplast A/S' ( CPH:COLO B ) price-to-earnings (or "P/E") ratio of 33.6x might make it look like a strong sell right...